Evidence map›Paper›PMID 35109849›Full record

ArticleBMC urology2022

PCGEM1 promotes proliferation, migration and invasion in prostate cancer by sponging miR-506 to upregulate TRIAP1.

He Liu, Xin He, Tianjiao Li, Yi Qu, Lina Xu, Yingnan Hou, Yao Fu, Hongzhi Wang

Open access · goldAbstract read
In one paragraph

Article in BMC urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. mFrontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

He Liu *Department of Urology, Heilongjiang Red Cross Sengong General Hospital, 32 Hexing Rd, Xiangfang District, Harbin, 150001, Heilongjiang Province, China.
Xin He *Department of General Surgery, Heilongjiang Red Cross Sengong General Hospital, Harbin, 150001, Heilongjiang Province, China.
Tianjiao LiDepartment of Urology, Heilongjiang Red Cross Sengong General Hospital, 32 Hexing Rd, Xiangfang District, Harbin, 150001, Heilongjiang Province, China.
Yi QuDepartment of Urology, Heilongjiang Red Cross Sengong General Hospital, 32 Hexing Rd, Xiangfang District, Harbin, 150001, Heilongjiang Province, China.
Lina XuDepartment of Urology, Heilongjiang Red Cross Sengong General Hospital, 32 Hexing Rd, Xiangfang District, Harbin, 150001, Heilongjiang Province, China.
Yingnan HouDepartment of Urology, Heilongjiang Red Cross Sengong General Hospital, 32 Hexing Rd, Xiangfang District, Harbin, 150001, Heilongjiang Province, China.
Yao FuDepartment of Urology, Heilongjiang Red Cross Sengong General Hospital, 32 Hexing Rd, Xiangfang District, Harbin, 150001, Heilongjiang Province, China.
Hongzhi WangDepartment of Urology, Heilongjiang Red Cross Sengong General Hospital, 32 Hexing Rd, Xiangfang District, Harbin, 150001, Heilongjiang Province, China. wanghongzhiwhz@126.com.
Heilongjiang Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe important role of long noncoding RNAs (lncRNAs) in cancer has been demonstrated in many studies. Prostate cancer gene expression marker 1 (PCGEM1) is a lncRNA specifically expressed within the prostate and overexpressed in many cancer cells. Numerous studies have shown that PCGEM1 promotes cell proliferation, invasion and migration. However, the specific mechanism of PCGEM1 within prostate cancer (PCa) has not been elucidated. MicroRNA-506-3p (miR-506-3p) is a noncoding RNA, and studies have indicated that miR-506-3p is downregulated in prostate cancer cell lines and functions as a tumor suppressor.

methodsThe TCGA (GEPIA) database ( http://gepia.cancer-pku.cn/ ) was employed to measure PCGEM1 levels in PCa. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to determine the PCGEM1 gene level. CCK-8 (Cell Counting Kit-8) and colony formation assays were used to detect cell proliferation, and Transwell assays were applied to assess cell invasion and migration. The interacting ability of miR-506-3p with PCGEM1 or TRIAP1 was validated through a dual-luciferase reporter assay. TRIAP1 protein expression was detected by Western blotting.

resultsPCGEM1 expression was increased in PCa tissues and cells. In PCa tissues, High PCGEM1 expression was associated with high Gleason score, distant metastasis and extracapsular extension. In addition, PCGEM1 knockdown inhibited PCa cell (C4-2B and PC-3) proliferation, invasion and migration. miR-506-3p may interact with PCGEM1 or TRIAP1, and the suppressive effect of PCGEM1 knockdown was reversed when TRIAP1 or a miR-506-3p inhibitor was cotransfected.

conclusionPCGEM1 expression increased in PCa cells and tissues, enhancing PCa cell proliferation, migration and invasion by sponging miR-506 to upregulate TRIAP1.

Indexed as

Gene Expression Regulation, NeoplasticUp-RegulationAnimalsCell MovementCell ProliferationHumansIntracellular Signaling Peptides and ProteinsMaleMicroRNAsModels, AnimalNeoplasm InvasivenessPrognosisProstatic NeoplasmsRNA, Long NoncodingTumor Cells, CulturedIntracellular Signaling Peptides and ProteinsMicroRNAsMIRN506 microRNA, humanPCGEM1 non-coding RNA, humanRNA, Long NoncodingTRIAP1 protein, humanCircular RNAsmiR‑506‑3pPCGEM1Prostate cancerTRIAP1

Identifiers

PMID35109849
PMCPMC8808993
OpenAlexW4221012528

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.